Breaking News

ATMI LifeSciences, Austar Complete Beijing Facility

ATMI, Inc. has opened a new biopharma manufacturing facility in Beijing, China as part of a joint venture with Austar.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ATMI, Inc. has opened a new biopharma manufacturing facility in Beijing, China as part of a joint venture with Austar, a Hong Kong-based pharmaceutical service provider. The joint venture, ATMI Austar LifeSciences Ltd., is aimed at producing and marketing high-end, ultra-clean sterile materials packaging for APIs and sterile pharmaceutical components to the biopharma industry in the Asia-Pacific region. ATMI Austar LifeSciences will produce certain ATMI LifeSciences products, including Cleans...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters